51
Views
20
CrossRef citations to date
0
Altmetric
Original Articles

A Comparison of the Potency of Newly Developed Oximes (K005, K027, K033, K048) and Currently Used Oximes (Pralidoxime, Obidoxime, HI-6) to Reactivate Sarin-Inhibited Rat Brain Acetylcholinesterase By in Vitro Methods

, &
Pages 677-686 | Received 09 Sep 2004, Accepted 22 Oct 2004, Published online: 24 Feb 2007

References

  • Bakshi,K. S. , Pang,S. N. J. , and Snyder,R. ,2000. Review of the US Army`s health risk assessment for oral exposure to six chemical-warfare agents—Introduction to the special issue ,J. Toxicol. Environ. Health A 59 (2000), p. 281,[CSA].
  • Bieger,D. , and Wassermann,O. ,1967. Ionization constants of cholinesterase reactivating bis-pyridinium aldoxime ,J. Pharm. Pharmacol. 19 (1967), pp. 844–847,[PUBMED] [INFOTRIEVE].
  • Cabal,J. , Kuca,K. , and Kassa,J. ,2004. Specification of the structure of oximes able to reactivate tabun-inhibited acetylcholinesterase ,Pharmacol. Toxicol. 95 (2004), pp. 81–86,[CROSSREF].
  • Clement,J. G. ,1994. Toxicity of the combined nerve agents GF/GB in mice: Efficacy of atropine and various oximes as antidotes ,Arch. Toxicol. 68 (1994), pp. 64–66,[PUBMED] [INFOTRIEVE] [CROSSREF].
  • Dawson,R. M. ,1994. Review of oximes available for treatment of nerve agent poisoning ,J. Appl. Toxicol. 14 (1994), pp. 317–331,[PUBMED] [INFOTRIEVE] [CSA].
  • Hammond,P. I. , Kern,C. , Hong,F. , Kollmeyer,T. M. , Pang,Y. P. , and Brimijoin,S. ,2003. Cholinesterase reactivation in vivo with a novel bis-oxime optimized by computer-aided design ,J. Pharmacol. Exp. Ther. 307 (2003), pp. 190–196,[PUBMED] [INFOTRIEVE] [CSA] [CROSSREF].
  • Kassa,J. ,2002. Review of oximes in the antidotal treatment of poisoning by organophosphorus nerve agents ,J. Toxicol. Clin. Toxicol. 40 (2002), pp. 803–816,[PUBMED] [INFOTRIEVE] [CSA] [CROSSREF].
  • Kassa,J. , and Cabal,J. ,1999. A comparison of the efficacy of a new asymmetric bispyridinium oxime BI-6 with presently used oximes and H oximes against sarin by in vitro and in vivo methods ,Hum. Exp. Toxicol. 18 (1999), pp. 560–565,[PUBMED] [INFOTRIEVE] [CSA] [CROSSREF].
  • Kiffer,D. , and Minard,P. ,1986. Reactivation by imidazo-pyridinium oximes of acetylcholinesterase inhibited by organophosphates. A study with an immobilized enzyme method ,Biochem. Pharmacol. 35 (1986), pp. 2527–2533,[PUBMED] [INFOTRIEVE] [CSA] [CROSSREF].
  • Koplovitz,I. , and Stewart,J. R. ,1994. A comparison of the efficacy of HI-6 and 2-PAM against soman, sarin and VX in the rabbit ,. Toxicol. Lett. 70 (1994), pp. 269–279,[PUBMED] [INFOTRIEVE] [CSA] [CROSSREF].
  • Kuca,K. , and Cabal,J. ,2004. Newly developed oximes (K005, K033, K027, K048) and their potency to reactivate VX-inhibited acetylcholinesterase ,Zprav. Voj. Farm. 14 (2004), pp. 13–16, (in Czech).[CSA].
  • Kuca,K. , and Kassa,J. ,2003. A comparison of the ability of a new bispyridinium oxime-1-(4-hydroxyiminomethylpyridinium)-4-(4-carbamoylpyridinium)butane dibromide and currently used oximes to reactivate nerve agent-inhibited rat brain acetylcholinesterase by in vitro methods ,J. Enzyme Inhib. Med. Chem. 18 (2003), pp. 529–535,[PUBMED] [INFOTRIEVE] [CROSSREF].
  • Kuca,K. , Bielavsky,J. , Cabal,J. , and Bielavska,M. ,2003a. Synthesis of a potential reactivator of acetylcholinesterase 1-(4-hydroxyiminomethylpyridinium)-3-(carbamoylpyridinium)-propane dibromide ,Tetrahedron Lett. 44 (2003a), pp. 3123–3125,[CROSSREF].
  • Kuca,K. , Bielavsky,J. , Cabal,J. , and Kassa,J. ,2003b. Synthesis of a new reactivator of tabun inhibited acetylcholinesterase ,Bioorg. Med. Chem. Lett. 13 (2003b), pp. 3545–3547,[PUBMED] [INFOTRIEVE] [CROSSREF].
  • Kuca,K. , Patocka,J. , and Cabal,J. ,2003c. Reactivation of organophosphate inhibited acetylcholinesterase activity by α,ω-bis (4-hydroxyiminomethylpyridinium) alkanes in vitro ,J. Appl. Biomed. 1 (2003c), pp. 207–211.
  • Kuca,K. , Cabal,J. , Patocka,J. , and Kassa,J. ,2004. Synthesis of bisquaternary symmetric χ,δ-bis(2-hydroxyiminomethylpyridinium)alkane dibromides and their reactivation of cyclosarin-inhibited acetylcholinesterase ,Lett. Org. Chem. 1 (2004), pp. 84–86,[CROSSREF].
  • Lamb,J. C. , Steinberg,G. M. , and Hackley,B. E. ,1966. Isopropyl methylphosphonylated bisquaternary oximes; powerful inhibitors of cholinesterase ,Biochim. Biophys. Acta 89 (1966), pp. 174–176.
  • Nachmansohn,D. ,1971. Chemical events in conducting and synaptic membranes during electrical activity ,Proc. Natl. Acad. Sci. USA 68 (1971), pp. 3170–3174,[PUBMED] [INFOTRIEVE].
  • Ohtomi,S. , Takase,S. , and Kumagai,F. ,1996. Sarin poisoning in Japan. A clinical experience in Japan Self Defense Force (JSDF) Central Hospital ,Int. Rev. Arm. Ser. 69 (1996), pp. 97–102.
  • Sevelova,L. , Kuca,K. , Krejcova,G. , and Vachek,J. ,2004. Therapeutic efficacy of oxime treatment in cyclosarin-poisoned mice pretreated with a combination of pyridostigmine, benactyzine and trihexyphenidyle ,J. Appl. Biomed. 2 (2004), pp. 163–167, .
  • Tallarida,R. , and Murray,R. ,1987. Manual of pharmacological calculation with computer programs .New York:Springer-Verlag;1987. p. 145.
  • Worek,F. , Kirchner,T. , and Szinicz,L. ,1995. Effects of atropine and bispyridinium oximes on respiratory and circulatory function in guinea-pig poisoned by sarin ,Toxicology 95 (1995), pp. 123–133,[PUBMED] [INFOTRIEVE] [CSA] [CROSSREF].
  • Worek,F. , Widmann,R. , Knopff,O. , and Szinicz,L. ,1998. Reactivating potency of obidoxime, pralidoxime, HI-6 and HLö-7 in human erythrocyte acetylcholinesterase inhibited by highly toxic organophosphorus compounds ,Arch. Toxicol. 72 (1998), pp. 237–243,[PUBMED] [INFOTRIEVE] [CROSSREF].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.